Related by context. All words. (Click for frequent words.) 72 allogeneic hematopoietic stem cell 71 transplantation HCT 70 transplantation HSCT 70 haematopoietic 69 allogeneic bone marrow 69 allogenic 68 hematologic disorders 68 allogeneic stem cell 68 pancreatic adenocarcinoma 68 Hematopoietic 67 hematopoietic stem cell 67 kidney urologic 67 stem cell engraftment 67 pancreatic islet 67 metastatic neuroendocrine tumors 67 cisplatin resistant 66 allogeneic transplants 66 myelofibrosis polycythemia vera 66 haematopoietic stem cell 66 Carcinoid tumors 66 Allogeneic 66 Systemic lupus erythematosus SLE 66 allogeneic hematopoietic cell 66 hematopoietic blood 65 ADPKD 65 mismatched bone marrow 65 colorectal carcinoma 65 papillary renal cell carcinoma 65 CYT# potent vascular disrupting 65 neoplastic 65 K ras mutations 65 Host Disease GvHD 65 myeloproliferative neoplasms 65 undergoing hematopoietic stem 64 autologous hematopoietic stem cell 64 pretransplant 64 GvHD 64 allogeneic HSCT 64 hematopoietic 64 prostatic tissue 64 haematologic malignancies 64 skeletal metastases 64 Gleevec resistant 64 mononuclear cells 64 hematopoietic cells 64 Umbilical cord stem cells 64 carcinoid 64 metastatic malignant 64 Leukemias 64 gefitinib Iressa 64 pancreatic islet cell 64 extramedullary 64 GRNOPC1 contains 64 hypereosinophilic syndrome 64 hypervascular tumors 64 Myelofibrosis 64 BRAF V#E 64 bronchogenic carcinoma 64 chronic granulomatous disease 64 carcinoid tumors 64 cervical lymph nodes 64 Ribavirin causes 64 Cojocaru correspondent 64 pancreatic carcinoma 64 clonogenic 64 renal allograft 64 complement inhibitor eculizumab 64 GI GVHD common 64 myelomas 64 vinca alkaloid 64 Fabry Disease 64 Ischemic 64 Treg cell 63 Myelodysplastic Syndrome 63 insulin secreting beta 63 Atypical Hemolytic Uremic Syndrome 63 Host Disease 63 leiomyoma 63 Lupus nephritis 63 renal tumors 63 kidney allograft 63 Progenitor Cells 63 Islet cell 63 tumoral 63 metaplasia 63 SSc 63 mucinous 63 vWD 63 umbilical vein 63 paroxysmal nocturnal hemoglobinuria 63 atypical hemolytic uremic syndrome 63 bone marrow stem cell 63 primary hyperparathyroidism 63 dilated cardiomyopathy DCM 63 pancreatic tissue 63 syngeneic 63 immunomodulation 63 hamartomas 63 recurrent glioblastoma multiforme 63 metastatic gastric 63 Mesenchymal 63 LHRH receptor positive 63 CD# + [001] 63 transplant HSCT 63 colorectal adenocarcinoma 63 chronic eosinophilic leukemia 63 neuroendocrine cancers 63 renal cell carcinomas 63 atypical Hemolytic Uremic Syndrome 63 prostate carcinoma 63 Vascugel 63 interleukin IL -# 63 mTOR inhibitors 63 dyskeratosis congenita 63 infarcted myocardium 63 Adult Stem Cell Therapy 63 renal tubular 63 Sezary syndrome 63 NAGS deficiency 63 liver metastasis 62 inducible nitric oxide synthase 62 VEGF inhibitors 62 unresectable tumors 62 neurotrophic 62 neoplastic cells 62 Acute Radiation Syndrome ARS 62 Critical Limb Ischemia CLI 62 cardiac allograft vasculopathy 62 Transplant Rejection 62 thoracic aortic aneurysms 62 KRAS oncogene 62 p# biomarker 62 biliary tree 62 orthotopic 62 Hereditary angioedema HAE 62 Embolization 62 uricase 62 Autologous stem cell 62 Hepatocellular Carcinoma HCC 62 retinal ischemia 62 glial tumors 62 Lymphoid 62 autologous transplants 62 breast carcinomas 62 renal transplantation 62 mesangial 62 NSCLC tumors 62 metastatic malignant melanoma 62 thoracic aortic aneurysm 62 EGFR receptor 62 hepatorenal syndrome 62 Epidermal Growth Factor Receptor 62 Endometrial 62 familial amyloidotic polyneuropathy FAP 62 steroid refractory 62 mononuclear 62 antibody mediated 62 factor PlGF 62 HbF 62 cerebrospinal fluid CSF 62 kidney fibrosis 62 lymphomas leukemias 62 small molecule activators 62 Immunosuppression 62 Fibroblast 62 bone marrow lymph nodes 62 peritoneal carcinomatosis 62 anti angiogenic agents 62 CTAP# Capsules 62 demonstrated antitumor activity 62 cystic fibrosis chronic pancreatitis 62 FLT3 62 PDGF receptor 62 lymphoid cells 62 EGFR HER2 62 Decitabine 62 antibody mediated rejection 62 IPAH 62 haematologic 62 epithelial tumors 62 chemosensitivity 62 Soluble CD# 62 severe malignant osteopetrosis 62 lupus nephritis 62 parathyroid carcinoma 62 mesenchymal cell 61 gastric carcinoma 61 Immunosuppressive 61 Xanafide 61 mTOR mammalian target 61 CD# expressing 61 PROSTVAC VF 61 Graft versus 61 thiopurine drugs 61 pleural fluid 61 radiochemotherapy 61 BCL#A 61 microsphere therapy 61 Epstein Barr Virus EBV 61 paraganglioma 61 exocrine 61 FUSILEV enhances 61 ERK1 2 61 Hepatocytes 61 myocardial infarction ventricular fibrillation 61 APOL1 61 CsA 61 neovascularization 61 CellCept mycophenolate mofetil 61 intra abdominal abscess 61 hepatoma 61 ABCB1 61 A1PI 61 castrate resistant prostate cancer 61 LRP5 61 mutated K ras 61 microvessels 61 Clusterin 61 pDC 61 biliary tract cancer 61 ATIR 61 retinal pigment epithelial cells 61 pro angiogenic 61 gamma globin gene 61 esophageal carcinoma 61 graft dysfunction 61 leiomyomas 61 myeloproliferative disorders 61 Estrogen Receptor 61 relapsed leukemia 61 paragangliomas 61 targeted antifolate 61 cause cardiac channelopathies 61 Personalized Immunotherapy 61 osteoblast 61 oligodendrogliomas 61 relapsed ALL 61 trophoblast cells 61 ImmuKnow 61 receiving immunosuppressive therapy 61 mutated KRAS 61 TTR amyloidosis 61 arteriovenous fistula 61 IL #R 61 vWF 61 pancreatic ductal 61 HepaMate ™ 61 FGFR3 61 unspecialized cells 61 Chronic lymphocytic leukemia 61 intracranial hemorrhage ICH 61 Pseudomonas aeruginosa infections 61 MGd 61 allogeneic transplant 61 NF kappaB activation 61 hESC derived 61 Candida infection 61 hypoxia inducible factor 61 renal fibrosis 61 lymphoid organs 61 aortic valve stenosis 61 anti CD3 61 GORE TAG Device 61 hematological diseases 61 FGFR1 61 Anthracycline 61 urothelial 61 dialed Ybarra 61 metastatic GIST 61 Symadex 61 Pulmonary hypertension 61 pain palliation 61 retinoic acid receptor 61 fusion enhancers 61 Autologous 61 essential thrombocythemia ET 61 OnDose TM 61 leukemia AML 61 ATIR TM 61 myoblast 61 sCD# 61 Acute myeloid leukemia AML 61 autologous transplant 61 pancreatic islet cells 61 ADAMTS# 61 Metastases 61 renal parenchyma 61 chronic GVHD 61 immunosuppressive therapies 61 myopathies 61 neurite outgrowth 61 tumor metastases 61 seminomas 61 granulocyte 61 transplant HSCT recipients 61 Innate Immune 61 Eisenmenger syndrome 61 Hypertrophy 61 occlusive disease 61 TEL AML1 61 antiangiogenic therapy 61 Vidaza ® 61 Idiopathic Pulmonary Fibrosis 61 pulmonary hypertension PH 61 cilengitide 61 monocytes macrophages 61 HLA matched 61 Trofex 61 Granulocyte Colony Stimulating Factor 61 cytotoxic effects 61 Hematopoietic stem cells 61 histological subtype 61 stage IIIA 61 MP4OX 61 metastatic pancreatic 61 Li Fraumeni 61 lung adenocarcinomas 61 Akt activation 61 Protein Kinase C 61 cytolytic 61 cytomegalovirus CMV 61 metabolomic profiles 61 carcinoma HCC 61 osteogenic 61 Immunotherapeutic 60 ischemia reperfusion injury 60 renal transplants 60 sarcomatoid 60 microcirculatory improvement helping 60 HepDirect prodrug 60 matching marrow donor 60 systemic lupus erythematosus SLE 60 retinal pigment epithelium 60 Immunosuppressive drugs 60 androgen receptor AR 60 ENMD # 60 Waldenstrom macroglobulinemia 60 L asparaginase 60 pancreatic endocrine 60 alkylating 60 immunocompetent 60 lactate dehydrogenase LDH 60 essential thrombocythemia 60 stem cell transplantations 60 novel VDA molecule 60 poly ADP ribose polymerase 60 Basal Cell 60 von Hippel Lindau 60 HIF 1a 60 Beta catenin pathway 60 thalidomide Thalomid 60 HIV HCV coinfected 60 neovascularisation 60 intraventricular 60 polycythemia vera PV 60 β cell 60 de novo kidney transplant 60 hematological malignancy 60 fulminant hepatic failure 60 thymidylate synthase TS 60 carcinoid tumor 60 ANCA associated 60 BEXXAR Therapeutic Regimen 60 gastrointestinal stromal tumors GIST 60 immune modulator 60 NOD SCID mice 60 cTnI 60 Endothelial 60 coagulation abnormalities 60 Belldegrun 60 relapsed MM 60 mesenchymal stem cell 60 TRAIL induced apoptosis 60 calcineurin inhibitor 60 coagulation cascade 60 Fc receptor 60 Inhaled nitric oxide 60 haematopoietic stem cells 60 Sipuleucel T 60 acute GvHD 60 Metastatic 60 histone acetylation 60 adipogenic 60 castrate resistant 60 urothelial cancer 60 fibrin deposition 60 Smac mimetics 60 Diabetic Foot Ulcer 60 Tyrosine Kinase Inhibitors 60 transarterial 60 nutlin 3a 60 sunitinib Sutent 60 mycophenolate mofetil 60 cardiac myocytes 60 cytopenias 60 VSELs 60 autosomal dominant polycystic kidney 60 glioblastoma tumor 60 HER2 receptor 60 Cutaneous T 60 hematopoetic stem cells 60 Fibrosis 60 pheochromocytoma 60 intestinal mucosa 60 receptor inhibitor 60 therapeutic regimens 60 recombinant erythropoietin 60 cells hESCs 60 PLX STROKE targeting 60 venous malformations 60 Azacitidine 60 Litx 60 glucocerebroside primarily 60 activin 60 hypoperfusion 60 nitrotyrosine 60 Meningiomas 60 serum phosphate 60 Biliary 60 plasma kallikrein 60 Glucocorticoid 60 intimal hyperplasia 60 Sertoli cells 60 KRAS mutant 60 Virulizin ® 60 IL 1ß 60 Hematopoietic stem cell 60 matrix metalloproteinases 60 chemoresistant 60 alpha folate receptor 60 BMPR2 60 esophageal candidiasis 60 Myelodysplastic syndromes 60 upregulating 60 metastatic tumors 60 relapsed multiple myeloma 60 Acute myeloid leukemia 60 Bronchiectasis 60 xenograft tumors 60 undifferentiated stem cells 60 Drug Prevents 60 gastrointestinal stromal tumor GIST 60 lactate dehydrogenase 60 aHUS 60 endothelial activation 60 isoenzyme 60 Cholangiocarcinoma 60 selective inhibition 60 nonvascular 60 B7 H3 60 breast cancer metastasis 60 CYP#A# CYP#D# 60 GISTs 60 polycystin 60 antiproliferative effects 60 Antithrombin 60 cholinergic neurons 60 thrombi 60 TGF b 60 DNA methyltransferases 60 intestinal polyps 60 serine proteases 60 galiximab 60 T#I [002] 60 VEGF induced 60 Malignant tumors 60 accumulate preferentially 60 autologous transplantation 60 adenomatous 60 peptibody 60 hematopoiesis 60 transfusion syndrome 60 epithelia 60 Tumor Necrosis Factor 60 polycythemia vera essential thrombocythemia 60 vorinostat 60 Prolastin A1PI 60 Cardiotoxicity 60 C5aR 60 Pancreatic 60 EXJADE 60 nonsense mutation 60 Chronic myeloid leukemia CML 60 Platinol ® cisplatin 60 molecular biomarkers 60 hepatectomy 60 disease GVHD 60 diseases chronic granulomatous 60 JAK3 60 CK # administered 60 Progenitor cells 60 JAK inhibitors 60 erlotinib Tarceva ® 60 prostate epithelial cells 60 Elotuzumab 60 myelodysplastic myeloproliferative diseases 60 intensity allogeneic stem 60 mycosis fungoides 60 tumorigenicity 60 diagnostic biomarker 60 immunologically matched 60 follicular lymphomas 60 Th2 cytokines 60 Hepatocellular Carcinoma 60 Myeloperoxidase 60 CMV seropositive 60 Papillary 60 thrombin receptor 60 Peripheral Blood 60 breast endometrial 60 TTR FAP 60 chronic myocardial ischemia 60 adult chronic ITP 60 Natalizumab 60 CCL# 60 Hemophilia B 60 Liver transplantation 60 erythropoietic 60 choroidal 60 NeoLipid R 60 hematopoietic progenitor cells 60 synovial tissue 60 Tr DNA 60 carcinoids 60 aplasia 60 immunosuppressive regimens 60 cirrhosis liver failure 60 proliferative disorders 60 CMV disease 60 mesenchymal stem cells MSCs 60 allogeneic SCT 60 OGG1 60 factor G CSF 60 chronic myeloid 60 acinar 60 recurrent glioblastoma 60 induces apoptosis 59 Vidofludimus 59 solid organ transplantation 59 neoplastic diseases 59 prostate carcinomas 59 bone morphogenetic proteins 59 mutant p# 59 alpha GAL 59 prostate bladder 59 pituitary adenoma 59 PTPN# 59 AAT Deficiency 59 targeted radiotherapeutic 59 Doxil ® 59 colorectal liver metastases 59 imatinib Gleevec 59 Relapsed Refractory 59 extrahepatic 59 remyelination 59 submandibular gland 59 aortic dissections 59 Acute lymphoblastic leukemia 59 intestinal mucosal 59 serine protease 59 5 Fluorouracil 59 PIK3CA 59 HBeAg negative 59 Corgentin 59 Lung transplantation 59 TIMP 1 59 Histologically 59 proteoglycan 59 hematopoietic malignancies 59 microvascular endothelial cells 59 GRNCM1 59 investigational monoclonal antibody 59 Fas ligand 59 Heterozygous 59 thymectomy 59 cell transplantation 59 autologous SCT 59 homozygous FH 59 deacetylase inhibitors 59 hematological parameters 59 Chronic Myeloid Leukemia CML 59 malignant prostate 59 IMiDs ® compound 59 HEK# 59 Lymph node 59 HER2 overexpression 59 non mutated KRAS 59 unstable angina pectoris 59 IVIG therapy 59 lymphocytosis 59 rituximab Rituxan 59 inherited retinal degeneration 59 hypophosphatasia 59 Mesenchymal stem cells 59 Omacetaxine 59 urothelial carcinoma 59 benign neoplasms 59 Transverse myelitis 59 esophagogastric 59 malignant pancreatic 59 leukemia lymphoma multiple myeloma 59 hepatic stellate cells 59 invasive aspergillosis 59 endocrine therapies 59 advanced individualized immunotherapies 59 prostanoid 59 Diffuse Large B 59 Fludara ® 59 Myelodysplastic Syndrome MDS 59 Delayed Graft Function 59 NGAL 59 JMML 59 Angiotensin converting enzyme 59 transarterial chemoembolization 59 immunomodulatory therapy 59 Cell Transplants 59 YONDELIS 59 HuCNS SC ® 59 IFN beta 59 NPM1 mutation 59 Cell Lymphoma CTCL 59 endoluminal stent graft 59 myeloproliferative diseases 59 candidemia 59 serum phosphorous 59 FVIII 59 adult mesenchymal stem 59 nephron 59 urethral stricture 59 pediatric acute lymphoblastic 59 prostate cancer CaP 59 hemodialysis patients 59 cisplatin chemotherapy 59 proto oncogene 59 squamous 59 removed laparoscopically 59 AA amyloidosis 59 corticosteroid dexamethasone 59 Oocyte 59 malignant neoplasm 59 allogeneic 59 MAPCs 59 squamous cell carcinoma SCC 59 ERBB2 59 Coronary Artery Bypass Graft 59 eccrine 59 Endologix Powerlink System 59 KRAS mutation 59 Cloretazine 59 intestinal epithelium 59 bronchoalveolar lavage fluid 59 MALT lymphoma 59 engineered RAP peptides 59 Hypotension 59 noninfectious uveitis 59 MKC# MKC# PP 59 mixed hyperlipidemia 59 prostaglandin synthesis 59 kinase inhibition 59 PTLD 59 functional mitral regurgitation 59 DNA methylation patterns 59 VEGFR1 59 MYDICAR ® 59 Antitumor Activity 59 ocular disorders 59 cytoreduction 59 Systemic lupus erythematosus 59 biliary tract 59 motor neuron degeneration 59 gynecologic procedures 59 Cyclosporine 59 progressive dyspnea 59 underwent resection 59 lenalidomide dexamethasone 59 Huntingtin 59 basal cell nevus syndrome 59 malperfusion 59 Nilotinib 59 pleural effusions 59 tumor lysis syndrome 59 ductal carcinomas 59 intracerebral 59 Heavy menstrual bleeding 59 alpha#beta# integrin 59 Thalomid ® 59 AGTR1 59 Monocyte 59 oligodendrocyte progenitor cells 59 Regenerative Cells 59 TTR gene 59 flavopiridol 59 malignant ascites 59 intrahepatic 59 catheter occlusion 59 pathophysiological effects 59 Severe Primary IGFD 59 proliferative retinopathy 59 cyclophosphamide methotrexate 59 CD4 + CD# 59 osteoblastic 59 intercellular signaling 59 Acute Decompensated Heart Failure 59 NMIBC 59 Vertebral Fractures 59 alkylating agent 59 V#F mutation 59 proximal tubule 59 Idiopathic Pulmonary Fibrosis IPF 59 Enzyme Replacement Therapy 59 Heart Transplant Recipients 59 azacytidine 59 Fibroblasts 59 Chronic HCV 59 operable breast cancer 59 Alocrest 59 thymic carcinoma 59 thoracoscopic lobectomy 59 erythropoiesis 59 TACI Ig 59 busulfan 59 transgenic rats 59 unresectable liver cancer 59 HER1 59 NKG2D 59 Myelodysplastic syndromes MDS 59 ST Elevation Myocardial 59 intracranial aneurysms 59 β cells 59 neural progenitor cells 59 Chronic Lymphocytic Leukemia CLL 59 Leydig cells 59 Fibrinogen 59 drug zotarolimus 59 Metastatic breast cancer 59 acute humoral rejection 59 immunomodulatory properties 59 IAP inhibitor 59 liver grafts 59 JAK2 enzyme 59 epididymal 59 ovarian carcinoma 59 cerebral ischemia 59 Pericardial 59 Microalbuminuria 59 Germline 59 Oral Mucositis 59 Trastuzumab 59 Follicular Lymphoma 59 insulin secreting 59 inhibiting tumor 59 breast cancer subtypes 59 thymosin beta 4 59 supratentorial 59 Erythropoietic therapies may 59 cyclin E 59 Ataluren 59 HepaLife TM 59 colon carcinoma 59 cisplatin gemcitabine 59 tumors GIST 59 Oncogenic 59 gastric carcinomas 59 stented vessel 59 hyperphenylalaninemia HPA due 59 Glufosfamide 59 TNF α 59 anemias 59 candidates Azedra TM 59 cytotoxic T lymphocyte 59 commercialize deforolimus 59 Plasmin 59 neovascular 59 effector function 59 apoptotic pathway 59 Radiofrequency ablation 59 hepatocellular carcinoma liver 59 recombinant tissue plasminogen 59 transthyretin 59 Lupus Nephritis 59 Macrophage 59 carotid plaque 59 Tumor Response 59 depsipeptide 59 experimental autoimmune encephalomyelitis 59 Squamous 59 C1 INH 59 hepatocellular carcinoma 59 Vorinostat 59 bone metastasis 59 nephrogenic fibrosing dermopathy 59 calcineurin 59 histone deacetylase inhibitor 59 terlipressin 59 myeloma cells 59 cellular prion protein 59 monocyte chemoattractant protein 59 neurofibromas 59 antiangiogenic agent 59 keratoplasty 59 gemcitabine Gemzar 59 abdominal aortic 59 non myeloablative 59 transthyretin amyloidosis 59 erlotinib Tarceva 59 cellularity 59 acinar cells 59 Alessandro Riva 59 systemic amyloidosis 59 acute myeloid 59 PNH patients 59 Soft Tissue Sarcoma 59 HLA markers 59 posttransplant 59 fibrotic disease 59 BHT DNA 59 chronic renal disease 59 CMV reactivation 59 hA# 59 autoinflammatory diseases 59 recurrent metastatic ovarian cancer 59 1 diabetes T1D 59 gastric adenocarcinoma 59 myeloablative 59 cardio renal 59 metastatic lesions 59 PI3K AKT 59 neurotrophic factors 59 endocrine pancreas 59 leukapheresis 59 IMiDs 59 bone marrow aspirates 59 Cardiomyocytes 59 xenograft 59 p# activation 59 immunosuppressive regimen 59 potent antiproliferative 59 hepatocellular carcinomas 59 Cathepsin B 59 HAAH 59 protein tyrosine phosphatase 59 PSMA ADC 59 deep venous thromboses 59 cystic lesions 59 HuLuc# 59 peripheral blood mononuclear 59 treat benign prostatic 59 trophoblastic 59 eosinophilic pneumonia 59 immunoregulatory 59 antiphospholipid syndrome 59 cAMP signaling 59 anti CD3 antibody 59 LHON 59 adipose derived stem cells 59 Acute Renal Failure 59 HSCT 59 TACE 59 cytotoxin 59 carcinoembryonic antigen 59 Daclizumab 59 membranous nephropathy 59 localized renal 59 Ebstein anomaly 59 epithelial tissues 59 synovial cells 59 Polymorphisms 59 severe neutropenia 59 AML MDS 59 eIF 4E 58 interferon alpha IFN alpha 58 NF kB pathway 58 calcineurin inhibitors 58 lung fibrosis 58 cell lymphoma ALCL 58 TGFß 58 Lymphocytic 58 osteochondroma 58 Aprotinin 58 Glucocorticoids 58 pelvic lymphadenectomy 58 metastatic ocular 58 GATA3 58 Glioma 58 variceal hemorrhage 58 angiogenic responses 58 idiopathic thrombocytopenic purpura ITP 58 pulmonary metastasis 58 relapsed ovarian cancer 58 lesional 58 pancreatic prostate 58 androgen deprivation 58 relapsing remitting MS RRMS 58 Factor VIIa 58 AAT deficiency 58 Langerhans cell histiocytosis 58 transplanted bone marrow 58 stromal vascular fraction 58 preoperative chemotherapy 58 EGFR tyrosine kinase inhibitors 58 nonmyeloablative 58 autologous bone marrow 58 Bayer HealthCare Onyx Pharmaceuticals 58 Interferon beta 58 glomerulonephritis 58 organizations OPOs 58 valvular 58 gene rearrangements 58 thoracic aortic 58 recurrent NSCLC 58 TNFR 58 Autoantibodies 58 Hormone Refractory Prostate Cancer 58 Chronic pancreatitis 58 mononuclear cell 58 ventricular myocardium 58 fibrogenesis 58 Advanced Renal Cell 58 Stromal 58 myeloperoxidase 58 hepatocellular 58 smoldering myeloma 58 sFlt 1 58 radiation chemoradiation 58 bleomycin 58 HepG2 cells 58 Stereotactic Body Radiation Therapy 58 stem progenitor cells 58 Ectopic pregnancy 58 MMP2 58 5 HT2A inverse 58 CD# monoclonal antibody 58 contractile function 58 refractory chronic lymphocytic 58 cells MSCs 58 Epithelial 58 elacytarabine 58 aplastic anemia AA 58 riociguat 58 immunologically compatible 58 thrombogenic 58 ESBA# 58 SGLT2 58 adipose stem cells 58 invasive candidiasis 58 HuMax 58 metachronous 58 mTOR inhibition 58 cytotoxicity assays 58 periodontal tissues 58 glioblastoma tumors 58 trastuzumab Herceptin ® 58 muscular dystrophies 58 VE cadherin 58 ductal adenocarcinoma 58 Renal Function 58 Ischemia reperfusion injury 58 NKT cell 58 collagens 58 Dupuytren Disease 58 bone marrow transplantations 58 Endothelial Cells 58 pleural mesothelioma 58 cyclosporin 58 vaso occlusive crisis 58 immunohistochemical staining 58 Antiangiogenic 58 R sorafenib tablets 58 glial derived neurotrophic 58 MMP inhibitors 58 K ras 58 Subarachnoid hemorrhage 58 keratinocyte 58 PLX cells 58 ectopic expression 58 transgenic mice expressing 58 subcutaneous immunoglobulin 58 echocardiographic parameters 58 multiple myeloma MM 58 germline mutations 58 N Myc 58 secondary hyperparathyroidism 58 Hepatic 58 adriamycin 58 porcine derived 58 secretes insulin 58 placental derived 58 Deforolimus 58 WT1 58 Allograft 58 GIST tumors 58 xenograft models 58 TO AVOID PREGNANCY WHILE 58 diabetes mellitus DM 58 bacterial foodborne illness 58 vimentin 58 Dacogen decitabine 58 receptor mediated endocytosis 58 leukemic cell